Creative Biolabs Blog

Menu

Skip to content
  • Drug Discovery Research
  • Immunotherapy Research
  • Antibody Engineering Research

Category Archives: Immunotherapy Research

30Oct/17

Chinese Scientists Discovered Strong Oncolytic Virus Synergist

October 30, 2017Immunotherapy Research, NewsCAR-T, ERAD pathway, M1, oncolytic virusbiolabs

On August 24th, a reporter was informed from Prof. Guangmei Yan research group at Zhongshan University that this group of researchers identified and gained oncolytic virus M1 synergist with accurate treatment ofRead More…

11Sep/17
An autoimmune disease is a pathological condition resulting from an abnormal immune response to tissues that can exist in the body,

Car-T for Autoimmune Disease and Blastoma Therapy

September 11, 2017Immunotherapy ResearchAutoimmune Disease, Blastoma Therapy, CAR-Tbiolabs

Car-T for Autoimmune Disease An autoimmune disease is a pathological condition resulting from an abnormal immune response to tissues that can exist in the body, affecting up to 50 million Americans in termsRead More…

07Sep/17
Carcinoma is a type of cancer that originates in epithelial cells

The Application of CAR-T in Disease Treatment

September 7, 2017Immunotherapy ResearchCAR-T, Carcinoma Therapy, Leukemia therapy, Lymphoma therapybiolabs

Chimeric antigen receptor (CAR) modified T cells (CAR-T) as a new field of adoptive immune cell therapy has become a hot spot in recent research. In 1989, Israeli scholar Gross et al.Read More…

03Sep/17

The Exploration of CAR T Cells Validation

September 3, 2017Immunotherapy ResearchCAR T cell validation, CAR-T, T -cells animal testbiolabs

Chimeric antigen receptor (CAR) T cells have hit the cancer immunotherapy area in the past few years. ‘A CAR therapy for cancer, using a technique called adoptive cell transfer, has been approvedRead More…

01Sep/17

Carl June Published His Latest Paper: The Results of CAR-T Therapy Human Trials on the Treatment of Solid Tumors Shows Two Hurdles Still Need to Be Overcome!

September 1, 2017Immunotherapy Research, NewsCAR-T, CAR-T transfusion, CART-EGFRvIII, CTL019biolabs

In this month, FDA oncologic Drugs Advisory Committee agreed to the approval of Novartis’s CAR-T CTL019 therapy on a vote of 10:0 for the treatment of relapsed or refractory children and youngRead More…

31Aug/17

Is Bio-distribution Study Necessary for CAR-T Therapy?

August 31, 2017Immunotherapy ResearchCAR-T, CAR-T cell biodistribution studybiolabs

Biological therapy includes a variety of models, such as immunotherapy, gene therapy, regulation of angiogenesis therapy, small molecule targeting drugs and stem cells and tissue engineering regenerative medicine. Among them, cancer immunotherapyRead More…

22Aug/17

The Development of CAR Gene Construction

August 22, 2017Immunotherapy ResearchCAR gene constructs, car t generation, car t structure, CAR-T, universal car tbiolabs

CAR-T is chimeric antigen receptor T cell immunotherapy, which modifies T cell receptor by CAR and transforms it into the scFV segment in the binding domain of monoclonal antibodies. A classic CAR-TRead More…

17Aug/17

The Introduction of T Cell Proliferation Assay  

August 17, 2017Immunotherapy ResearchCAR-T, T cell proliferation assay, TCR T cell culturebiolabs

Cell proliferation is an important vital sign of the organism in a splitting manner. Single-celled organisms produce new individuals in the form of cell division, while a multicellular organism that produces newRead More…

16Aug/17

Revelation! CAR-T Has Its “Eyes” on Solid Tumor and the Treatment of That Would Be Possible

August 16, 2017Immunotherapy Research, Newscancer, CAR-T, immunotherapy, tumorbiolabs

Immunotherapy has become a new hope against cancer. CAR-T cell therapy is achieved by using genetic engineering method to express chimeric antigen receptors on T cells obtained from donner patients. These chimericRead More…

14Aug/17

Comparison between CAR-T and TCR-T

August 14, 2017Immunotherapy ResearchCAR-T, high affinity TCRbiolabs

As a matter of fact, tumor immunotherapy is divided into two categories. One is to show immune cells the tumor features, then direct them to locate and kill tumor cells. And anotherRead More…

Posts navigation

  • « Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next »

Categories

  • Antibody Engineering Research
  • Biological Knowledge
  • Drug Discovery Research
  • Immunotherapy Research
  • News

Recent Posts

  • Scientists identify a special gene that produces key antibodies in large quantities
  • The molecular mechanism by which special antibodies protect the body against HIV infection
  • Multispecific antibodies enhance cancer immunotherapy
  • Scientists have cracked HIV’s new way of entering the host cell nucleus, which may lead to new therapeutic drugs
  • Antibody sequencing provides a new path for antibody therapy research

Archives

Contact Us

USA – UK

Copyright © Creative Biolabs Blog
Powered by WordPress , Theme i-max by TemplatesNext.
MENU
  • Drug Discovery Research
  • Immunotherapy Research
  • Antibody Engineering Research